Vaccine

A second shot of Johnson & Johnson’s vaccine provides 100% protection against severe or critical COVID-19 when given two months after a first dose, according to new data.

A vaccine candidate developed to protect vulnerable adults against the common respiratory syncytial virus has shown 80% efficacy in reducing the risk of dangerous lower respiratory tract diseases such...

A 50-microgram dose appears to be effective enough to increase waning vaccine protection, and may reduce the risk of side effects, sources tell investigators.

New data from vaccine maker Pfizer and Israel’s health ministry may help U.S. health agencies make a case for recommending COVID-19 booster shots, various sources report.

The benefits of the shot — including reduced hospitalization, intensive care unit admission and death — outweigh the risk of contracting Guillain-Barre syndrome, the Advisory Committee on Immunization...

I’ve been thinking quite a bit about trust over the last week or so, especially after reading a real pick-me-up in the Washington Post about how the pandemic will lead to the splintering of societies....

Nursing home, senior living and aging advocates are pushing the federal government to commit to allocating between 50,000 and 75,000 weekly COVID-19 doses to long-term care pharmacies enrolled in the Pharmacy...

There were no COVID-19-related deaths or cases requiring medical intervention four weeks or more after vaccination in adults age 60 and older. But there were not enough participants aged 75 and older to...

Nursing homes that completed its first vaccine clinic saw COVID-19 cases decrease at a faster rate when compared to facilities that had yet to administer any doses, according to a new, first-of-its-kind...

You had to look only in one place for a pair of fascinating long-term care stories this week.